宝利化

Bolyhua is a specialized biotechnology company focused on high-end drug delivery technologies, particularly lipid-based systems like liposomes and lipid nanoparticles (LNPs). Based in Beijing, the company offers a comprehensive platform for the formulation, process development, and manufacturing of complex injectables and nucleic acid therapeutics. Bolyhua serves as a CDMO for partners developing mRNA vaccines and difficult-to-formulate small molecules while maintaining an internal pipeline of improved therapeutic candidates. Their expertise spans from early-stage R&D to GMP-compliant commercial production, positioning them as a key player in the Chinese drug delivery landscape.